Genocea Biosciences (GNCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock GNCAQ vs. CALA, SCPS, EVLO, CMRA, GNCA, ARDS, STAB, SMFL, AMPE, and EFTRShould you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include Calithera Biosciences (CALA), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Smart for Life (SMFL), Ampio Pharmaceuticals (AMPE), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry. Genocea Biosciences vs. Calithera Biosciences Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma Smart for Life Ampio Pharmaceuticals eFFECTOR Therapeutics Genocea Biosciences (NASDAQ:GNCAQ) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, community ranking, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings. Which has stronger valuation & earnings, GNCAQ or CALA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenocea BiosciencesN/AN/AN/AN/AN/ACalithera BiosciencesN/AN/A-$39.65MN/AN/A Is GNCAQ or CALA more profitable? Company Net Margins Return on Equity Return on Assets Genocea BiosciencesN/A N/A N/A Calithera Biosciences N/A N/A N/A Does the MarketBeat Community believe in GNCAQ or CALA? Calithera Biosciences received 341 more outperform votes than Genocea Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformGenocea BiosciencesN/AN/ACalithera BiosciencesOutperform Votes34155.36% Underperform Votes27544.64% Which has more volatility and risk, GNCAQ or CALA? Genocea Biosciences has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -1.13, meaning that its share price is 213% less volatile than the S&P 500. Does the media prefer GNCAQ or CALA? In the previous week, Calithera Biosciences had 1 more articles in the media than Genocea Biosciences. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Genocea Biosciences. Genocea Biosciences' average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score. Company Overall Sentiment Genocea Biosciences Neutral Calithera Biosciences Neutral SummaryCalithera Biosciences beats Genocea Biosciences on 2 of the 3 factors compared between the two stocks. Get Genocea Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GNCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNCAQ vs. The Competition Export to ExcelMetricGenocea BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$6,000.00$2.95B$5.53B$7.93BDividend YieldN/A1.89%5.11%4.22%P/E RatioN/A30.0722.5918.54Price / SalesN/A494.82401.35103.29Price / CashN/A168.6838.1834.62Price / BookN/A3.176.774.25Net IncomeN/A-$72.35M$3.22B$248.18M Genocea Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070CALACalithera BiosciencesN/A$0.01flatN/AN/A$24,000.00N/A0.0060SCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-98.9%$9,000.00N/A0.00120Options VolumeCMRAComera Life SciencesN/A$0.00flatN/A-99.7%$6,000.00$1.00M0.002GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.8%$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/A-85.7%$5,000.00N/A0.0020SMFLSmart for LifeN/A$0.00+33.3%N/A-100.0%$3,000.00$11.11M0.00110Gap UpAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.8%$2,000.00N/A0.0020Analyst ForecastEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010Gap Up Related Companies and Tools Related Companies Calithera Biosciences Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Smart for Life Competitors Ampio Pharmaceuticals Competitors eFFECTOR Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GNCAQ) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genocea Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNCAQ Stock Free GNCAQ Stock Alerts